EUVIMEDEUVIMED entdecken
Crossref

A Validated UPLC–MS/MS Assay for Isosakuranetin Determination in Rat Plasma and Its Application to Pharmacokinetics

Mengzhi Xu, Xiaoyu Huang, Shuman Xue, Chengrui Hu, Congcong Wen iD, Xianqin Wang iD

Biomedical Chromatography · 2026-07 · 40 (7)

DOI: 10.1002/bmc.70511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 07.06.2026. Verfasst von Mengzhi Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First People's Hospital of Yuhang District, Hangzhou, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Flavonoids. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isosakuranetin is a natural flavonoid containing a 4′‐O‐methyl group on the molecular structure and has a broad range of pharmacological activities. In this study, a sensitive and robust UPLC‐ESI‐MS/MS method was developed and fully validated for quantitative determination of isosakuranetin in rat plasma, enabling a comprehensive evaluation of the pharmacokinetics and oral bioavailability of isosakuranetin. Isoscoparin was the internal standard (IS). The plasma samples were prepared by protein precipitation with acetonitrile. Chromatographic separation was conducted with a BEH C18 column and a gradient mobile phase consisting of acetonitrile and 0.1% formic acid aqueous solution. The detection was accomplished in negative electrospray ionization (ESI) by multiple reaction monitoring (MRM) mode. The assay had excellent linearity (r > 0.995) in a linear concentration range of 0.5–800 ng/mL. Precision (intra‐ day and inter‐day) was less than 13%, and extraction recovery was above 89%. Accuracy was between 91% and 113%, and the matrix effects were 93%–104%. Overall, this method was rapid, specific, reproducible, and sufficiently sensitive for in vivo pharmacokinetic studies in rats. After oral administration, the absolute bioavailability of isosakuranetin was calculated to be 64.6%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryFlavonoidsAnimalsRatsReproducibility of ResultsChromatography, High Pressure LiquidMaleRats, Sprague-DawleyLinear ModelsDrug StabilityLimit of DetectionSensitivity and SpecificityBiological Availability

Stichwörter der Autor:innen

UPLC–MS/MSbioavailabilityisosakuranetinpharmacokineticsrat

Substanzen

Flavonoidsisosakuranetin

Autor:innen und Institutionen

  • Department of Orthopedics, The First People's Hospital of Yuhang District, Hangzhou, China.
  • Laboratory Animal Centre, Wenzhou Medical University, Wenzhou, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Congcong Wen, Xianqin Wang

Zitieren

APA

Xu, M., Huang, X., Xue, S., Hu, C., Wen, C., & Wang, X. (2026). A Validated UPLC–MS/MS Assay for Isosakuranetin Determination in Rat Plasma and Its Application to Pharmacokinetics. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70511

Vancouver

Xu M, Huang X, Xue S, Hu C, Wen C, Wang X. A Validated UPLC–MS/MS Assay for Isosakuranetin Determination in Rat Plasma and Its Application to Pharmacokinetics. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70511

BibTeX
@article{Xu2026,
  author = {Xu, Mengzhi and Huang, Xiaoyu and Xue, Shuman and Hu, Chengrui and Wen, Congcong and Wang, Xianqin},
  title = {A Validated UPLC–MS/MS Assay for Isosakuranetin Determination in Rat Plasma and Its Application to Pharmacokinetics},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1002/bmc.70511}
}
Kostenlos starten →